Virus-HIV
Clinical trials for Virus-HIV explained in plain language.
Never miss a new study
Get alerted when new Virus-HIV trials appear
Sign up with your email to follow new studies for Virus-HIV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can one daily dose of raltegravir keep HIV in check?
Disease control CompletedResearchers are testing whether a once-daily form of raltegravir can keep HIV suppressed in adults who already have the virus under control with standard antiretroviral therapy. The trial enrolls about 100 adults with HIV-1 who have been on stable treatment for at least six month…
Matched conditions: VIRUS-HIV
Phase 2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Survey reveals missed chances for HIV prevention
Knowledge-focused CompletedThis study surveyed 596 people in France who were newly diagnosed with HIV. The goal was to find out why they did not use pre-exposure prophylaxis (PrEP), a medicine that prevents HIV infection. By understanding these missed opportunities, researchers hope to improve how PrEP is …
Matched conditions: VIRUS-HIV
Sponsor: French National Agency for Research on AIDS and Viral Hepatitis • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC